AmerisourceBergen Corporation--Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


FORM 8-K

 


CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): July 31, 2007

 


AmerisourceBergen Corporation

(Exact name of Registrant as specified in its charter)

 


 

Delaware   1-16671   23-3079390

(State or Other Jurisdiction of

Incorporation or Organization)

  Commission File Number  

(I.R.S. Employer

Identification Number)

 

1300 Morris Drive

Chesterbrook, PA

  19087
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (610) 727-7000

N/A

(Former name or former address, if changed since last report.)

 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 8.01. Other Events.

On July 31, 2007, AmerisourceBergen Corporation (the “Registrant”), Kindred Healthcare, Inc. (“Kindred”) and PharMerica Corporation (“PharMerica”) issued a news release announcing the completion of the spin-offs of Registrant’s and Kindred’s institutional pharmacy services businesses to form PharMerica. A copy of the news release is filed as Exhibit 99.1 to this report and incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

99.1 News Release, dated July 31, 2007, regarding the completion of the spin-offs and combination of Registrant’s and Kindred’s institutional pharmacy services businesses to form PharMerica.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    AMERISOURCEBERGEN CORPORATION
Date: July 31, 2007     By:  

/s/ Michael D. DiCandilo

    Name:   Michael D. DiCandilo
    Title:   Executive Vice President and Chief Financial Officer